Arenamides A−C, Cytotoxic NFκB Inhibitors from the Marine Actinomycete Salinispora arenicola
- 31 December 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 72 (3) , 396-402
- https://doi.org/10.1021/np800617a
Abstract
Three new cyclohexadepsipeptides, arenamides A−C (1−3), were isolated from the fermentation broth of a marine bacterial strain identified as Salinispora arenicola. The planar structures of these compounds were assigned by detailed interpretation of NMR and MS/MS spectroscopic data. The absolute configurations of the amino acids, and those of the chiral centers on the side chain, were established by application of the Marfey and modified Mosher methods. The effect of arenamides A and B on NFκB activity was studied with stably transfected 293/NFκB-Luc human embryonic kidney cells induced by treatment with tumor necrosis factor (TNF). Arenamides A (1) and B (2) blocked TNF-induced activation in a dose- and time-dependent manner with IC50 values of 3.7 and 1.7 μM, respectively. In addition, the compounds inhibited nitric oxide (NO) and prostaglandin E2 (PGE2) production with lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. Moderate cytotoxicity was observed with the human colon carcinoma cell line HCT-116, but no cytotoxic effect was noted with cultured RAW cells. Taken together, these data suggest that the chemoprevention and anti-inflammatory characteristics of arenamides A and B warrant further investigation.This publication has 26 references indexed in Scilit:
- Biosynthesis and Structures of Cyclomarins and Cyclomarazines, Prenylated Cyclic Peptides of Marine Actinobacterial OriginJournal of the American Chemical Society, 2008
- Marine natural productsNatural Product Reports, 2008
- Species-Specific Secondary Metabolite Production in Marine Actinomycetes of the Genus SalinisporaApplied and Environmental Microbiology, 2007
- NF‐κB activation in development and progression of cancerCancer Science, 2007
- NF-κB as a target for cancer therapyEmerging Therapeutic Targets, 2007
- Developing a new resource for drug discovery: marine actinomycete bacteriaNature Chemical Biology, 2006
- NF-κB inhibition: A double-edged sword in cancer?European Journal Of Cancer, 2006
- NF-κB and IKK as therapeutic targets in cancerCell Death & Differentiation, 2006
- Nuclear Factor-κB: A Holy Grail in Cancer Prevention and TherapyCurrent Signal Transduction Therapy, 2006
- Determination ofD-amino acids. II. Use of a bifunctional reagent, 1,5-difluoro-2,4-dinitrobenzeneCarlsberg Research Communications, 1984